DDOG vs DHR: Which Is the Better Buy?
Side-by-side comparison of Datadog, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Datadog, Inc. · Technology
$126.61
+194.6% upside to fair value
Grade C
High Quality
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
DDOG has more upside to fair value
(+194.6%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DDOG |
DHR |
| Current Price |
$126.61 |
$174.04 |
| Fair Value Estimate |
$373.02 |
$197.01 |
| Upside to Fair Value |
+194.6%
|
+13.2%
|
| Market Cap |
$44.8B |
$123.2B |
| Forward P/E |
412.3x
|
33.4x
|
| EV / EBITDA |
202.3x
|
20.3x
|
| Price / Sales |
13.1x
|
5.0x
|
| Price / FCF |
44.8x
|
23.3x
|
| Revenue Growth YoY |
+29.2%
|
+3.7%
|
| Gross Margin |
79.9%
|
60.7%
|
| Operating Margin |
-1.3%
|
21.0%
|
| Return on Equity |
3.2%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.23%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Datadog, Inc. operates a leading cloud-based observability and security platform that drives high customer retention and multi-product adoption, supporting strong revenue growth of 28% year-over-year in fiscal 2025 to $3.43 billion. The company benefits from a usage-based subscription model with 85% of customers using two or more products, creating switching costs and a growing moat. Despite this…
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
DDOG |
DHR |
| Zone Low |
$279.76 |
$147.76 |
| Zone High |
$317.07 |
$167.46 |
| In Buy Zone? |
Yes
|
No
|